Comparison with commercial immunoassays as key step in the performance evaluation of an immunosuppressant TDM HPLC-MS/MS platform in a clinical environment: P56


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles